Cite
MLA Citation
D. Cocito et al.. “Feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience.” Clinical neurophysiology, vol. 130, no. 1, n.d., pp. e12–. http://access.bl.uk/ark:/81055/vdc_100074897021.0x00000f